Apyx Medical (Nasdaq:APYX) - Aktienkurs, Nachrichten und Analyse

APYX Aktienübersicht

Apyx Medical Corporation, ein Energietechnologieunternehmen, ist in den Vereinigten Staaten und international in der Konzeption, Entwicklung und Herstellung von medizinischen Geräten tätig.

Über das Unternehmen

APYX grundlegende Analyse
Schneeflocken-Punktzahl
Bewertung	3/6
Künftiges Wachstum	1/6
Vergangene Leistung	0/6
Finanzielle Gesundheit	5/6
Dividenden	0/6

Belohnungen

Prognostiziertes jährliches Umsatzwachstum 12.55%

Im Vergleich zu Wettbewerbern und der Branche gut bewertet

Risikoanalyse

Derzeit unrentabel und in den nächsten 3 Jahren nicht rentabel zu werden prognostiziert

Hat keine nennenswerte Marktkapitalisierung ($51M)

Volatiler Aktienkurs in den letzten 3 Monaten

Apyx Medical Corporation Wettbewerber

LENSAR

NasdaqCM:LNSR

US$50.4m

Milestone Scientific

NYSEAM:MLSS

US$51.7m

Vaso

OTCPK:VASO

US$42.1m

Neuronetics

NasdaqGM:STIM

US$54.9m

Preisentwicklung & Leistung

Übersicht über alle Höchststände, Veränderungen und Kursrückgänge für Apyx Medical
Historische Aktienkurse
Aktueller Aktienkurs	US$1.38
52-Wochen-Hoch	US$7.97
52-Wochen-Tief	US$1.21
Beta	1.25
11 Monat Veränderung	-13.75%
3 Monate Veränderung	7.81%
1 Jahr Veränderung	-81.72%
33 Jahre Veränderung	-87.02%
5 Jahre Veränderung	-80.14%
Veränderung seit IPO	-57.95%

Aktuelle Nachrichten und Updates

Is Apyx Medical (NASDAQ:APYX) Using Debt In A Risky Way?

Jun 19

Revenues Working Against Apyx Medical Corporation's (NASDAQ:APYX) Share Price Following 25% Dive

Apr 18

Recent updates

Is Apyx Medical (NASDAQ:APYX) Using Debt In A Risky Way?

Jun 19

Revenues Working Against Apyx Medical Corporation's (NASDAQ:APYX) Share Price Following 25% Dive

Apr 18

Apyx Medical Corporation (NASDAQ:APYX) Analysts Just Slashed This Year's Estimates

Mar 26

Take Care Before Diving Into The Deep End On Apyx Medical Corporation (NASDAQ:APYX)

Feb 16

Is Apyx Medical (NASDAQ:APYX) A Risky Investment?

Sep 14

Does Apyx Medical (NASDAQ:APYX) Have A Healthy Balance Sheet?

Jun 07

Forecast: Analysts Think Apyx Medical Corporation's (NASDAQ:APYX) Business Prospects Have Improved Drastically

Mar 21

Here's Why We're Watching Apyx Medical's (NASDAQ:APYX) Cash Burn Situation

Dec 14

We're Not Very Worried About Apyx Medical's (NASDAQ:APYX) Cash Burn Rate

Aug 30

Apyx Medical GAAP EPS of -$0.16 beats by $0.03, revenue of $10.3M misses by $0.26M

Aug 11

Apyx Medical gets FDA nod for Renuvion's use in improving loose skin on neck, chin

Jul 18

Companies Like Apyx Medical (NASDAQ:APYX) Are In A Position To Invest In Growth

May 26

Are Investors Undervaluing Apyx Medical Corporation (NASDAQ:APYX) By 42%?

Mar 15

Aktionärsrenditen

	APYX	US Medical Equipment	US Markt
7D	-6.1%	0.5%	0.1%
1Y	-81.7%	0.2%	24.1%

Rendite im Vergleich zur Industrie: APYX unter dem Niveau der Branche US Medical Equipment , die im vergangenen Jahr eine Rendite von -1% erzielte.

Rendite vs. Markt: APYX hinter dem Markt US zurück, der im vergangenen Jahr eine Rendite von 22.3 erzielte.

Preisvolatilität

Is APYX's price volatile compared to industry and market?
APYX volatility
APYX Average Weekly Movement	11.6%
Medical Equipment Industry Average Movement	7.8%
Market Average Movement	5.7%
10% most volatile stocks in US Market	15.4%
10% least volatile stocks in US Market	2.8%

Stabiler Aktienkurs: APYXDer Aktienkurs des Unternehmens war in den letzten 3 Monaten unbeständig.

Volatilität im Zeitverlauf: APYXDie wöchentliche Volatilität (14%) war im vergangenen Jahr stabil, liegt aber immer noch höher als bei 75 % der US Aktien.

Über das Unternehmen

Gegründet	Mitarbeiter	CEO	Website
1982	252	Charlie Goodwin	apyxmedical.com

Apyx Medical Corporation, ein Energietechnikunternehmen, ist in den Vereinigten Staaten und international in der Konzeption, Entwicklung und Herstellung von medizinischen Geräten tätig. Das Unternehmen ist in zwei Segmenten tätig: Advanced Energy und Original Equipment Manufacturing (OEM). Es bietet Heliumplasma-Generatoren für die Abgabe von HF-Energie und Heliumplasma zum Schneiden, Koagulieren und Abtragen von Weichgewebe bei offenen und minimal-invasiven chirurgischen Eingriffen an.

Apyx Medical Corporation's Grundlagenzusammenfassung

Wie verhalten sich die Erträge und Einnahmen von Apyx Medical im Vergleich zum Marktanteil des Unternehmens?
APYX grundlegende Statistiken
Marktanteil	US$47.81m
Gewinn(TTM)	-US$22.81m
Umsatz(TTM)	US$50.45m

0.9x

Kurs-Umsatz-Verhältnis

-2.1x

Kurs-Gewinn-Verhältnis

Ist APYX zu teuer?

Siehe Fair Value und Bewertungsanalyse

Erträge & Einnahmen

Wichtige Rentabilitätsstatistiken aus dem letzten Ergebnisbericht (TTM)
APYX Gewinn- und Verlustrechnung (TTM)
Einnahmen	US$50.45m
Kosten der Einnahmen	US$18.32m
Bruttogewinn	US$32.14m
Sonstige Ausgaben	US$54.94m
Umsatz	-US$22.81m

Zuletzt gemeldete Gewinne

Mar 31, 2024

Datum des nächsten Gewinnberichts

k.A.

Gewinn per Aktie (EPS)	-0.66
Bruttomarge	63.70%
Nettogewinnspanne	-45.20%
Schulden/Eigenkapital-Verhältnis	163.3%

Wie hat sich APYX auf lange Sicht entwickelt?

Historische Performance und Vergleiche

APYX Aktienübersicht

Belohnungen

Risikoanalyse

Apyx Medical Corporation Wettbewerber

NasdaqCM:LNSR

US$50.4m

NYSEAM:MLSS

US$51.7m

OTCPK:VASO

US$42.1m

NasdaqGM:STIM

US$54.9m

Preisentwicklung & Leistung

Aktuelle Nachrichten und Updates

Is Apyx Medical (NASDAQ:APYX) Using Debt In A Risky Way?

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Apyx Medical Corporation Reaffirms Earnings Guidance for the Full Year Ending December 31, 2024

New major risk - Revenue and earnings growth

Apyx Medical Corporation to Report Q1, 2024 Results on May 09, 2024

Revenues Working Against Apyx Medical Corporation's (NASDAQ:APYX) Share Price Following 25% Dive

Recent updates

Is Apyx Medical (NASDAQ:APYX) Using Debt In A Risky Way?

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Apyx Medical Corporation Reaffirms Earnings Guidance for the Full Year Ending December 31, 2024

New major risk - Revenue and earnings growth

Apyx Medical Corporation to Report Q1, 2024 Results on May 09, 2024

Revenues Working Against Apyx Medical Corporation's (NASDAQ:APYX) Share Price Following 25% Dive

Consensus revenue estimates fall by 17%

Apyx Medical Corporation (NASDAQ:APYX) Analysts Just Slashed This Year's Estimates

Apyx Medical Corporation Provides Earnings Guidance for the Year Ending December 31, 2024

Full year 2023 earnings: EPS misses analyst expectations

Apyx Medical Corporation to Report Q4, 2023 Results on Mar 21, 2024

Take Care Before Diving Into The Deep End On Apyx Medical Corporation (NASDAQ:APYX)

Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Evaluating the Safety of Renuvion® Following Liposuction in Multiple Areas of the Body

New major risk - Revenue and earnings growth

Apyx Medical Corporation Provides Preliminary Revenue Guidance for the Fourth Quarter and Full Year Ended December 31, 2023

Apyx Medical Corporation Appoints Matthew Hill as Chief Financial Officer, Effective December 4, 2023

Apyx Medical Corporation Announces Resignation of Tara Semb as Chief Financial Officer

Apyx Medical Corporation Announces Resignation of Tara Semb as Chief Financial Officer

New major risk - Share price stability

President recently bought US$79k worth of stock

Consensus revenue estimates fall by 11%

Apyx Medical Corporation announced that it expects to receive $45 million in funding

Price target increased by 16% to US$9.00

New minor risk - Market cap size

Apyx Medical Corporation to Report Q3, 2023 Results on Nov 09, 2023

Is Apyx Medical (NASDAQ:APYX) A Risky Investment?

New major risk - Revenue and earnings growth

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Apyx Medical Corporation Reaffirms Financial Guidance for the Year Ending December 31, 2023

New major risk - Share price stability

Executive Vice President exercised options and sold US$87k worth of stock

Apyx Medical Corporation to Report Q2, 2023 Results on Aug 10, 2023

Executive Vice President notifies of intention to sell stock

Apyx Medical Corporation, Annual General Meeting, Aug 10, 2023

Apyx Medical Corporation Announces FDA 510(k) Clearance for the Renuvion® Micro Handpiece

Does Apyx Medical (NASDAQ:APYX) Have A Healthy Balance Sheet?

Consensus estimates of losses per share improve by 15%

Price target increased by 33% to US$8.00

Apyx Medical Corporation Updates Earnings Guidance for the Year Ending December 31, 2023

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

Consensus revenue estimates increase by 11%

Forecast: Analysts Think Apyx Medical Corporation's (NASDAQ:APYX) Business Prospects Have Improved Drastically

Full year 2022 earnings: EPS misses analyst expectations

Apyx Medical Corporation to Report Q4, 2022 Results on Mar 16, 2023

Apyx Medical Corporation Announces FDA 510(K) Submission for the Use of the Renuvion® Apr. Handpiece for the Coagulation of Subcutaneous Soft Tissues Where Needed, Following Liposuction

Apyx Medical Corporation Launches New 'Apyx One Console' for Cosmetic Surgical Procedures in the United States

Apyx Medical Corporation Provides Revenue Guidance for the Fourth Quarter and Full Year 2022

Here's Why We're Watching Apyx Medical's (NASDAQ:APYX) Cash Burn Situation

Consensus revenue estimates fall by 15%

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Insufficient new directors

Price target decreased to US$10.33

Apyx Medical Corporation Updates Earnings Guidance for the Year Ending December 31, 2022

Apyx Medical Corporation to Report Q3, 2022 Results on Nov 10, 2022

Insufficient new directors

President recently bought US$70k worth of stock

We're Not Very Worried About Apyx Medical's (NASDAQ:APYX) Cash Burn Rate

Price target increased to US$14.00

Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Erträge & Einnahmen